Zealand Pharma Interim Report First Half 2020
Zealand Pharma held a conference call on August 13, 2020 at 4 pm CEST (10 am EDT) following the announcement of results for the first half of 2020.
Presenting during the call were President and Chief Executive Officer Emmanuel Dulac, Senior Vice President and Chief Financial Officer Matt Dallas, and Executive Vice President and Chief Medical Officer Adam Steensberg, and Mads Kronborg, Head of Investor Relations & Communication.
Download report
Zealand Pharma interim report for H1 2020
Replay webcast
https://edge.media-server.com/mmc/p/fxsmie47
Download presentation
Zealand Pharma H1 2020 presentation